On the basis of a review of recent epidemiology, the ICRP recently issued a statement outlining a new approach to radon. The ICRP indicates that the Publication 65 dose conversion convention will be replaced using the dosimetric approach currently used for other radionuclides. Moreover, the ICRP indicates that the dose conversion factor is expected to increase by about a factor of 2. This paper independently examines the risks associated with exposure to radon and decay products through estimation of lifetime excess absolute risks per WLM for a variety of epidemiological risk projection models and baseline cancer and mortality rates. This paper suggests that current ICRP dosimetric models do not reflect the effect of smoking and suggest that basic risk estimates and dose conversion factors be based on risks to non-smoking populations with recognition that lifestyle choices, especially smoking, have a large effect on the risk from exposure to radon.